Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    TARDBP
Show Display Options
Rank Status Study
1 Recruiting Tamoxifen Treatment in Patients With Motor Neuron Disease
Conditions: Amyotrophic Lateral Sclerosis;   ALS Functional Ration Scale;   TAR-DNA-binding Protein-43;   Tamoxifen;   mTOR
Intervention: Drug: tamoxifen 40 mg daily for one year

Indicates status has not been verified in more than two years